The global medical plastic compounds market size was valued at USD 74.57 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2030. Growing awareness regarding health issues and subsequent changes in regulatory policies concerning plastics usage are anticipated to have a considerable impact on a future growth trajectory. Increasing usage of sterilized and disposable devices and the need for longer shelf-life of medical devices are expected to further drive growth. The utilization of lightweight and cost-effective plastics and increasing use of prosthetics is anticipated to fuel the demand over the forecast period. The global increasing prevalence of chronic diseases has significantly driven the demand for healthcare services and products. The demand for medical plastic compounds increases as the need for more medical devices, diagnostic tools, and disposables increases. Plastics are essential in creating cost-effective, disposable medical products for infection control and ensuring sterility in healthcare.
As healthcare systems worldwide seek to reduce hospital admissions and cut costs, there is a rising preference for home-based care, particularly chronic disease management and elderly care. This shift has increased demand for portable, user-friendly medical devices and equipment in non-clinical settings. Medical plastic compounds are ideal for such applications due to their lightweight nature, durability, and ease of manufacturing. Products such as oxygen concentrators, home dialysis equipment, and wearable health monitors rely on plastic components to ensure they are practical for home use. This growing trend increases the demand for medical plastic compounds.
Strategic partnerships and collaborations among companies in the medical plastic compounds market are increasing as businesses seek to leverage expertise and resources to drive innovation and market expansion. These partnerships often involve material suppliers working closely with medical device manufacturers to develop customized plastic compounds that meet specific regulatory and performance requirements. By partnering, companies accelerate the development of new products, enhance their competitive advantage, and better meet the growing demands of the global healthcare market. For instance, in November 2022, DSM Engineering Materials formed a strategic partnership with Compounding Solutions to enhance the development of vascular catheters. This collaboration aims to streamline access to DSM's Care portfolio, which includes innovative materials such as Arnitel Care, designed as alternatives to traditional catheter materials. The partnership is expected to accelerate the medical devices company's time to market by leveraging Compounding Solutions' expertise in customizing catheter materials efficiently, providing quick development turnaround time, and ensuring supply reliability.
The polyvinylchloride segment dominated the market and accounted for a revenue share of 31.1% in 2023. Polyvinylchloride's ability to be easily molded and formed into various shapes allows it to be used in everything from flexible tubing to rigid containers. Due to its excellent flexibility, durability, and resistance to chemicals and bodily fluids, PVC is widely employed in products such as IV bags, blood bags, catheters, and respiratory masks. The adaptability of PVC to be combined with plasticizers and other additives also enhances its properties, making it suitable for specific medical applications that require particular characteristics such as transparency, biocompatibility, and stabilizability.
The acrylics segment is expected to register the fastest CAGR during the forecast period. Acrylics are durable and resistant to various chemicals, including disinfectants and cleaning agents, making them ideal for use in medical environments where hygiene is essential, and materials must withstand regular sterilization. Acrylics' resistance to UV light also ensures that medical products from this material remain stable and effective over time. This durability is necessary for reusable medical devices and equipment that maintain integrity after repeated use and sterilization. The long-lasting nature of acrylics supports their growing adoption in medical applications that demand reliability and longevity.
The disposables segment dominated the market with 23.5% share in 2023. This segment accounted for a significant market share owing to the increasing usage of sterilized and disposable syringes and gloves in the healthcare sector of the countries, such as Germany, China, India, and the U.K. Plastic compounds in disposable medical products require stringent infection control and patient safety. Disposable medical products, such as syringes, IV tubes, catheters, and surgical drapes, are designed for single use to prevent cross-contamination and the spread of infections. The healthcare industry's focus on reducing healthcare-associated infections has led to a growing demand for disposable products used once and then safely discarded. Medical plastic compounds are ideal for these applications due to their sterilization ability, biocompatibility, and capacity to form reliable barriers against pathogens. This need for infection control is necessary in hospitals, clinics, and surgical centers, driving the widespread use of disposables.
The drug delivery systems segment is anticipated to register a significant CAGR over the forecast period. The shift towards personalized medicine, where treatments are customized to individual patients, creates new demands for customized drug delivery systems. Medical plastic compounds enable the development of devices specialized to specific patient needs, such as personalized dosing systems or implantable devices that release medication over a defined period. The versatility of plastics in being molded and adapted to various forms makes them ideal for creating customized drug delivery solutions that require principles of personalized healthcare.
North America medical plastic compoundsmarket dominated the market in 2023. The presence of advanced hospitals, clinics, and research institutions creates a strong demand for high-quality medical devices and equipment from specialized plastic compounds. The region's healthcare providers require reliable, durable, and safe materials for various applications, from surgical instruments to diagnostic devices and drug delivery systems. The continuous investment in healthcare facilities and technologies in the U.S. and Canada ensures a steady demand for medical plastic compounds that meet this sector's stringent quality and performance standards.
The U.S. medical plastic compounds market is expected to witness significant CAGR over the forecast period. The trend toward home healthcare and telemedicine is gaining momentum in the U.S., particularly post COVID-19 pandemic. This shift drives demand for portable, easy-to-use medical devices that patients operate at home, such as blood glucose monitors, home dialysis equipment, and remote monitoring devices. These products require medical plastic compounds that are lightweight, durable, and safe for everyday use by non-professionals. The growing acceptance and adoption of home healthcare solutions in the U.S. are expanding the market for medical plastics.
The Asia Pacific medical plastic compounds market is expected to witness significant CAGR over the forecast period. As the population ages, there is an increasing need for medical devices and solutions that cater to age-related health issues, such as cardiovascular diseases, diabetes, and orthopedic conditions. This demographic shift drives demand for a wide range of medical products, from implantable devices to home healthcare equipment, which rely on specialized plastic compounds. Additionally, rising healthcare expenditure in the region supports the growth of the medical devices market, increasing the demand for medical plastic compounds.
The China medical plastic compounds market accounted for the largest revenue share in 2023. The growing focus on personalized and precision medicine in China drives demand for specialized medical devices for individual patients’ needs. This approach requires medical plastic compounds that are easily customized and adapted to create customized devices, such as patient-specific implants, drug delivery systems, and diagnostic tools. The ability to personalize medical devices with precision is critical in ensuring effective treatment outcomes, particularly in complex cases involving chronic diseases or rare conditions. Medical plastics that offer versatility in design, biocompatibility, and ease of manufacturing are essential to supporting the personalized medicine trend, driving the market in China.
The Europe medical plastic compounds market is expected to witness significant growth over the forecast period. Europe benefits from a well-established supply chain and distribution network supporting the efficient production and delivery of medical plastic compounds. This network includes raw material suppliers, plastic compounders, and medical device manufacturers, which work closely to ensure a consistent supply of high-quality materials. The region’s advanced logistics infrastructure facilitates the timely distribution of medical products, ensuring that healthcare providers access the necessary tools and devices. The reliability and efficiency of this supply chain are essential in meeting the standards of the Europe healthcare market, driving demand for medical plastic compounds.
The Latin America medical plastic compounds market is expected to witness the fastest CAGR over the forecast period. Patient safety and high-quality care are important concerns in the Latin America healthcare system. This focus has led to stringent standards for medical devices, including those made from plastic compounds. Medical plastic compounds used in devices and equipment must attach to strict safety guidelines to minimize risks associated with their use, such as contamination, material degradation, or adverse reactions. This emphasis on safety drives the need for high-performance plastics that are safe, reliable, and effective in clinical use.
Key players in medical plastic compounds market include BASF, Saint-Gobain Performance Plastics Pampus GmbH., DuPont, Teknor Apex and others.
The following are the leading companies in the medical plastic compounds market. These companies collectively hold the largest market share and dictate industry trends.
Report Attribute |
Details |
Market size value in 2023 |
USD 74.57 Billion |
Revenue forecast in 2030 |
USD 106.21 Billion |
Growth Rate |
CAGR of 5.2% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, Application, and Region |
Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Country scope |
U.S., Canada, Mexico, Germany, UK, Germany, France, Italy, Spain, Russia, Denmark, Sweden, Norway, China, India, Japan, Australia, South Korea, Indonesia, Vietnam, Brazil, Argentina, South Africa, South Arabia, UAE, and Kuwait |
Key companies profiled |
BASF, Dow, DuPont, Eastman Chemical Company, Evonik Industries AG, SABIC, Celanese Corporation, Tekni-Plex, Inc., RAUMEDIC AG, Solvay, Covestro AG, Trelleborg Group., Saint-Gobain Performance Plastics Pampus GmbH., Teknor Apex, Mitsubishi Chemical Group Corporation. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the medical plastic compounds market report based on product, application and region.
Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 - 2030)
Polyvinylchloride
Polyethylene
Polypropylene
Polystyrene
Polyester
Polycarbonate
Polyurethane
Acrylics
Others
Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 - 2030)
Disposables
Catheters
Surgical Instruments
Medical Bags
Implants
Drug Delivery System
Other
Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Russia
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
Australia
South Korea
Indonesia
Vietnam
Latin America
Brazil
Argentina
MEA
Saudi Africa
South Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."